Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX Announces Contract Award from U.S. Department of Homeland Security to Develop Foot-and-Mouth Disease Vaccine

ROCKVILLE, Md., Oct. 5, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has been awarded a $1.3 million contract from the U.S. Department of Homeland Security to develop a...
October 03, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports Positive Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate

- Well-tolerated with no systemic side-effect trends - Highly immunogenic with an increase in anti-RSV antibodies in 100% of subjects in the highest-dose group - Oral and poster...
September 26, 2011 08:00 ET | Source: Novavax, Inc.

Novavax to Report Top-Line Results From Phase I Respiratory Syncytial Virus Vaccine Clinical Trial on October 3rd at 5th Vaccine and ISV Annual Global Conference

ROCKVILLE, Md., Sept. 26, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report top-line results from a Phase I clinical trial of its respiratory syncytial virus...
September 08, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX Announces Publication of Results From H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial

VLP vaccine candidate was well-tolerated, immunogenic and generated cross-reactive neutralizing antibodies ROCKVILLE, Md., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced...
September 06, 2011 13:59 ET | Source: Novavax, Inc.

NOVAVAX to Present at Stifel Nicolaus Healthcare Conference

ROCKVILLE, Md., Sept. 6, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
August 16, 2011 08:00 ET | Source: Novavax, Inc.

Novavax to Present at the 2011 Wedbush Life Sciences Conference

ROCKVILLE, Md., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
August 05, 2011 08:00 ET | Source: Novavax, Inc.

Novavax Reports Second Quarter 2011 Financial Results

ROCKVILLE, Md., Aug. 5, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the second quarter ended June 30, 2011. Novavax reported a net loss of $5.0...
August 04, 2011 09:13 ET | Source: Novavax, Inc.

NOVAVAX and the Mexican Social Security Institute Publish Results From H1N1 Influenza Vaccine Trial in Mexico

ROCKVILLE, Md., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) and Specialties Hospital of the National Medical Center, Mexico City, today announced the publication of safety and...
July 29, 2011 15:51 ET | Source: Novavax, Inc.

Novavax to Report Second Quarter 2011 Financial Results on August 5, 2011

ROCKVILLE, Md., July 29, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the second quarter of 2011 on Friday, August 5, 2011, before the U.S. financial markets...
June 28, 2011 08:00 ET | Source: Novavax, Inc.

Novavax Appoints Dr. Timothy Hahn Senior Vice President of Manufacturing

ROCKVILLE, Md., June 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Timothy J. Hahn, Ph.D., as Senior Vice President of Manufacturing. Dr. Hahn will...